Barely Significant
← all excerpts

Prostanoid therapies in the management of pulmonary arterial hypertension.

Ther Clin Risk Manag · 2015 · PMC4386780 · PMID 25848300

Europe PMCDOI
1
hedged sentence
0.0510
closest p · 1.0× alpha
0.0510
boldest claim

The sentences

near-significantP =0.051so close (0.05 < p ≤ 0.1)
66 A subsequent randomized controlled trial using iloprost as add-on therapy to bosentan demonstrated near-significant improvements in 6MWD (placebo-adjusted difference 26 meters, P =0.051) and improvement in functional class and hemodynamics. 67 However, long-term stability on iloprost monotherapy has been questioned.

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.